Volume 27, Number 1—January 2021
Dispatch
Optimization of Notification Criteria for Shiga Toxin–Producing Escherichia coli Surveillance, the Netherlands
Ingrid H.M. Friesema
, Sjoerd Kuiling, Zsofia Igloi, and Eelco Franz
, Sjoerd Kuiling, Zsofia Igloi, and Eelco Franz
Table 2
Most prevalent genes in non-O157 Shiga toxin–producing Escherichia coli, the Netherlands, July 2007–June 2016 and July 2016–December 2019*
| Most prevalent genes, no. (%) |
July 2007–June 2016, n = 1,366 |
July 2016–December 2019, n = 292 |
|||||||
| eae |
hly |
eae + hly |
None |
eae |
hly |
eae + hly |
None |
||
| stx1 | 18 (1) | 170 (12) | 287 (21) | 130 (10) | 3 (1) | 7 (2) | 95 (33) | 10 (3) | |
| stx2 | 4 (0.3) | 99 (7) | 82 (6) | 173 (13) | 3 (1) | 18 (6) | 53 (18) | 35 (12) | |
| stx1 + stx2 | 0 | 158 (12) | 52 (4) | 30 (2) | 1 (0.3) | 12 (4) | 21 (7) | 6 (2) | |
| stx2f |
160 (12) |
0 |
0 |
3 (0.2) |
26 (9) |
0 |
1 (0.3) |
1 (0.3) |
|
| *eae, attaching and effacing gene; hly, hemolysin gene; stx1, Shiga toxin type 1 gene; stx2, Shiga toxin type 2 gene. |
|||||||||
Page created: November 23, 2020
Page updated: December 21, 2020
Page reviewed: December 21, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.